Market Tracker

07/25 2:21pm ET
Real-Time Quote
 -2.26 / -1.52%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-2.19% 3 years+25.73%
3 months+15.03% 5 years+22.32%
1 year+26.86% Since inception+14.17%
Data through 07/25/2014

Quote Details

Previous close$148.59
Open day’s range145.22 – 147.81
Net asset value (NAV)148.52 (07/24/2014)
Daily volume124,935
Average volume (3 months)580,592
Data as of 2:17pm ET, 07/25/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.32%+24.14%
Expense Gross exp ratio0.35%0.43%
Risk 5 year sharpe ratio1.021.52
Net assets$1.1B$1.4B
Average market cap$1.9B$25.9B
Average P/E--26.1
Dividend / Share--0.21%


VHT Vanguard Health Care ETF
XLV Health Care Select Sector SPDR┬« Fund
IXJ iShares Global Healthcare ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
INSM Insmed Inc1.98%
VRTX Vertex Pharmaceuticals Inc1.59%
GEVA Synageva BioPharma Corp1.55%
INO Inovio Pharmaceuticals Inc1.53%
ONVO Organovo Holdings Inc1.49%
NLNK NewLink Genetics Corp1.45%
ARWR Arrowhead Research Corp1.43%
RGEN Repligen Corp1.42%
DYAX Dyax Corp1.41%
VNDA Vanda Pharmaceuticals Inc1.40%